2 Mar
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

16 fév
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

9 fév
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

2 fév
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

12 jan
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

19 jan
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

5 jan
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

8 déc
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

1 déc
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

17 nov
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion
Subscribe to